Clinical Trial Update: PPARγ Agonist Treatment for Cocaine Dependence [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 1 and Phase 2 results for a PPAR gamma agonist being studied for cocaine use disorder, with participants also having al…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Cocaine Use Disorder

Drugs mentioned

• PPAR gamma agonist

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Cocaine Use Disorder, Alcohol Use Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-04-26